Community Academic Profiles–

Stephanie Van de Ven

Back to Profile

Publication Details

  • A novel fluorescent imaging agent for diffuse optical tomography of the breast: first clinical experience in patients.

    van de Ven S, Wiethoff A, Nielsen T, Brendel B, van der Voort M, Nachabe R, Van der Mark M, Van Beek M, Bakker L, Fels L, Elias S, Luijten P, Mali W. Mol Imaging Biol. 2010; 12 (3): 343-8

    This is the first clinical evaluation of a novel fluorescent imaging agent (Omocianine) for breast cancer detection with diffuse optical tomography (DOT).

    PubMedID: 19798535

Stanford Medicine Resources:

Footer Links: